GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SmyD3 in complex with covalent inhibitor 2

Analyse Crystal structure of SmyD3 in complex with covalent inhibitor 2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5XXG
Type
protein
Length
423 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.14
Source
Homo sapiens
Molecule
SMYD3
Ligands
8HR, SAM, ZN
Pockets
4 · best druggability 0.79

Structure

x-ray diffraction · resolution 2.14 · 1 distinct chain · 51% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASMYD3protein42351% helix, 13% strand—

Ligands and binding sites

  • 8HR · Propyl 4-(4-chloranyl-2-phenyl-quinolin-7-yl) carbonylpiperazine-1-carboxylate · ligand · chains A
  • SAM · S-adenosylmethionine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19060.790.81848HR
22040.580.8031SAM
31820.530.7931empty
41140.430.7727empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5XXG · Crystal structure of SMYD3 in complex with covalent inhibitor 2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.